Interim Results for the 6 months to 30 June 2026

Big Technologies PLC

14 September 2026

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

14 September 2026

BIG TECHNOLOGIES PLC
("Big Technologies" or the "Company" and, together with its subsidiaries the "Group")

UNAUDITED RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026

Big Technologies plc (AIM: BIG), a leading provider of electronic monitoring solutions today announces its unaudited results for the six months ended 30 June 2026 ("H1 2026").

Financial Highlights

·    Constant currency ARR¹ growth of 5% driven by strong new business success across the Americas and EMEA. ARR increased to £53.2m (H1 2025: £50.9m²)

·    Revenues of £26.9m (H1 2025: £24.8m, £25.4m on a constant currency basis²), constant currency growth of 6% driven by new business wins coming online in the period.

·    Resilient gross margins of 66.7% (H1 2025: 67.5%) reinforced by disciplined cost-base approach.

·    Adjusted EBITDA³ grew 14% to £14.2m (H1 2025: £12.5m) reflecting both the Group's growing revenue and disciplined cost-neutral approach to investment in 2025.

·    Adjusted Free Cash Flow⁴ was £9.6m compared with £6.7m in H1 2025. The increase of £2.9m Adjusted Free Cash Flow reflects the Group's strong underlying cash generation. Exceptional cash outflows in relation to legal fees reduced from £5.3m in H1 2025 to £2.6m in H1 2026.

·    Balance sheet remains strong following initial settlement payments in relation to the Buddi Litigation, with cash of £67.1m (H1 2025: £96.7m). Settlement payments of £33.4m were made in H1 2026.

Financial Progress

£m (unless otherwise stated)	H1 2026	H1 2025
Annual Recurring Revenue ("ARR") and Revenue
Total ARR	53.2	50.92
Revenue	26.9	25.42
Profit and EPS
Gross Margin	67%	68%
Adjusted EBITDA3	14.2	12.5
Adjusted EBITDA3 margin	53%	50%
Adjusted Operating Profit3	11.4	9.5
Statutory Operating Profit/(loss)	9.1	(27.1)
Adjusted basic Earnings per Share3	3.5	2.8
Cash and Balance Sheet
Cash at bank	67.1	96.7
Adjusted free cash flow4	9.6	6.7

Operational highlights

·    Contract awarded to Buddi and partner, Sonda SA, for the Gendarmerie of Chile. The contract is for 7 years with total revenues expected to be c. $26m.

·    Further success in Latin America following the recent award of the Peru contract, which is expected to generate $0.6m revenue over the two-year contract period, in addition to a recent award for a Mexican municipality.

·    US momentum continues to build, with recent contract wins in Westchester, New York, California, Ohio and Indiana, as well as the renewal of the statewide contract in Tennessee, reinforcing the scale of the opportunity in the Group's largest addressable market.

·    Guatemala renewal secured for 3-year period following a competitive tender process, demonstrating the reliability and value of the Buddi solution.

·    Settlement of the Buddi Litigation for £38.5m in January 2026. The Group continues to pursue the SM Proceedings and/or any settlement related thereto.

·    Well positioned for further growth in H2 2026 and beyond following the Chile contract win, three-year Guatemala renewal and six new wins in the US, supported by new product success with AlcoTag and AlcoBreath. Board is confident that results will be marginally ahead of market consensus⁵ for 2026.

Commenting on the results, Charles Lewinton, Acting CEO, said:

"I am delighted with the continued progress made by the Group in the first half of 2026. We have continued to perform strongly and are exceptionally well positioned in the electronic monitoring industry to accelerate growth in future periods.

Following a year of transition, I am particularly proud of how well the team has performed. Their focus, resilience and commitment have strengthened the Group, leaving us well positioned to push on with an excellent global team with our market-leading product set.

The Group's recent successes give us a strong platform from which to win more contracts, deepen our presence in existing markets and convert the significant pipeline of opportunities ahead."

¹ ARR is the value of continuing revenue from recurring accounts at a specific point in time, normalised to a one-year period. ARR is not recognised on contracts for which revenue has yet to commence.

² Constant currency is calculated by recalculating H1 2025 revenues using prevailing average foreign exchange rates from H1 2026, and by recalculating prior period ARR at the prevailing rate at the balance sheet date.

 ³Adjusted EBITDA and Adjusted Operating Profit exclude share-based payments and other adjusting items, including but not limited to provisions for legal expenses in relation to ongoing litigation and associated costs relating to the legal proceedings. Adjusted Operating Profit also excludes the amortisation of acquired intangibles. Adjusted Basic Earnings per Share excludes all of the above and the tax effect of these adjustments.

⁴Adjusted Free Cash Flow in the period is defined as Operating Cash Flows less capital expenditure excluding exceptional cash flows in the period. Exceptional cash flows in both periods include but are not limited to legal fee expenses incurred in relation to litigation. H1 2025 also excludes both a cash inflow of £5.2m in relation to the reversal of previously adopted tax treatment of a warrant exercised in 2021, and the cash outflow impact of an exceptional foreign exchange loss of £4.0m relating to funds held in USD in anticipation of an acquisition.

⁵The Group has compiled forecasts from five analysts, with current market forecasts for 2026 revenue to be in the range of £50.5m to £52.2m, with consensus of £51.1m, and for adjusted EBITDA to be in the range of £24.7m to £25.9m, with a consensus of £25.3m.

For further information please contact:

Big Technologies plc	[phone]
Sangita Shah (Interim Chair) Charles Lewinton (Acting Chief Executive Officer)
Mike Johns (Chief Financial Officer)
Zeus (Nominated Advisor and Joint Broker)	[phone]
Dan Bate / Kieran Russell (Investment Banking)
Nick Searle (Equity Capital Markets)
Singer Capital Markets (Joint Broker)	[phone]
James Moat / Shaun Dobson / James Todd (Investment Banking)

About Big Technologies plc

Our mission is to deliver innovative, high-quality electronic monitoring solutions that combine advanced hardware and software to support monitoring of individuals in our core criminal justice business.   Big Technologies is a market leader in the electronic monitoring industry, operating under the trusted 'Buddi' brand. Through its integrated technology platform, Buddi offers state-of-the-art Electronic Monitoring solutions on a subscription-based, SaaS-like model. This platform is highly flexible and scalable, enabling tailored deployments across diverse use cases and geographies.

For more information, please visit www.buddi.com

Forward-looking statements

This press release contains certain projections and other forward-looking statements with respect to the financial condition, results of operations, businesses and prospects of the Group. The use of terms such as "may", "will", "should", "expect", "anticipate", "project", "estimate", "intend", "continue", "target" or "believe" and similar expressions (or the negatives thereof) are generally intended to identify forward-looking statements. These statements are based on current expectations and involve risk and uncertainty because they relate to events and depend upon circumstances that may or may not occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Any of the assumptions underlying these forward-looking statements could prove inaccurate or incorrect and therefore any results contemplated in the forward-looking statements may not actually be achieved. Nothing contained in this press release should be construed as a profit forecast or profit estimate. Investors or other recipients are cautioned not to place undue reliance on any forward-looking statements contained herein. The Group undertakes no obligation to update or revise (publicly or otherwise) any forward-looking statement, whether as a result of new information, future events or other circumstances.

Overview

The Group has made a strong start to 2026 and has returned to growth and profitability in the first half of the year whilst maintaining the strong new business momentum from 2025.

Significant Opportunity

Buddi Limited ("Buddi") is exceptionally well positioned in the growing electronic monitoring market worldwide. Prison overcrowding is a global problem, and electronic monitoring provides a cost-effective solution.

Buddi's industry-leading portfolio of electronic monitoring solutions is uniquely positioned to address the complex and evolving challenges faced by governments and public sector agencies worldwide. The Group offers a comprehensive suite of Radio Frequency ("RF"), GPS and alcohol monitoring technologies, providing customers with a flexible and integrated platform that supports a wide range of public safety and offender management programmes.

Designed with security, reliability and wearer comfort at their core, Buddi's solutions deliver superior outcomes through increased wearer compliance and engagement, enhanced monitoring visibility, and a lower total cost of ownership. Continuous investment in innovation ensures that customers benefit from the latest advances in monitoring technology, a key factor underpinning Buddi's success in securing new contracts and renewing long-standing customer relationships.

Beyond its technology capabilities, Buddi has established itself as a trusted strategic partner to government agencies. The Group is recognised for consistently delivering high-quality services and support, combining operational excellence with deep sector expertise. Its proven track record of implementing complex programmes on time and to a consistently high standard has earned Buddi a strong reputation for reliability, responsiveness and customer success.

Alcohol Monitoring

Alcohol monitoring is the fastest growing area within the electronic monitoring industry and Buddi has two market-leading solutions; the AlcoTag and AlcoBreath. The AlcoTag has been in the market for 2 years and has shown significant growth in that time, setting a new standard for combined Alcohol and GPS solutions.

AlcoTag combines real-time alcohol monitoring with live GPS tracking, allowing officials to intervene swiftly in the event of non-compliance. The AlcoTag is the only solution able to combine both real-time alcohol and live location monitoring. The Group is currently developing the second iteration of the model which will significantly reduce the size of the unit, while ensuring no loss of functionality.

AlcoBreath is the Group's newest offering, and is already receiving strong interest and uptake. The product is targeted toward compliance-based cohorts and allows a more discreet solution that continues to monitor both alcohol intake and location. The AlcoBreath is the only remote breath product on the market which includes real time tracking options, fully automated facial recognition, spoofing detection, and accurate breath alcohol readings.

The inherent complexity in the production of alcohol monitoring products allows for higher margins on these products than the Group's other products. The acceleration of growth of these products in the US reinforces the regional margin, despite the competitive nature of the electronic monitoring market in the US.

Location Monitoring

The Group has solutions for both GPS and RF monitoring, as well as solutions supporting victims of domestic violence. The Group has also been developing a wrist-worn solution with a partner to complete the Group's offering to governments.

Buddi's GPS solution, SmartTag, includes various technologies not seen in some other solutions such as combined location tracking, shielding detection and dual SIM cards. The SmartTag continues to receive upgrades with future versions already in development to increase GPS accuracy, battery life and robustness.

New Business Wins

The Group's return to growth has been underpinned by its strong performance in new business. Revenue growth in the first half was driven by contract wins achieved in H2 2025, including Lithuania, Latvia, Prince Edward Island, and multiple wins across the US and other European jurisdictions.

This momentum has continued in the period, with the Group, together with its partner, Sonda SA, awarded a contract with the Gendarmerie in Chile. The Group also continued to win contracts across the US in the first half of 2026, with 23 wins in the period.

Following the period end, the Group has achieved further new business success, securing a contract in Peru, further strengthening the Group's growing presence in Latin America.

Renewal Success

The Group has also been successful in driving a client focused mindset across the business, which has resulted in a resilient and loyal client base.

In the first half, the Group succeeded in renewing its Guatemala contract for a further three-year period. This renewal followed other extensions during H2 2025 in Australia. Client happiness remains a key focus for the team and continued renewals are testament to the hard work of the wider team in driving client focused results.

People and organisation

Following the appointment of Charles Lewinton as Acting CEO, the Group's leadership has been streamlined, with a smaller number of globally accountable leaders in the business. This approach allows the Group to take a coordinated approach commercially and operationally. Among other key leadership changes, Mike Johns has taken the position of Chief Operating Officer in conjunction with his role as Chief Financial Officer. Completing the Group's streamlined leadership team are Sarah Bodel, who becomes Chief Commercial Officer, and Chris Jakeman, who becomes Chief Technology Officer.

The executive team is supported by our highly capable colleagues in the wider business, delivering best in class service to our expanding global client base.

Outlook

Following a strong first half of the year and positive new business and renewal momentum following the period end, the Board is now confident that performance will be marginally ahead of market expectations⁵ for 2026.

Financial Performance

The Group delivered a strong financial performance in the first half of 2026, demonstrating a return to growth and profitability, supported by resilient gross margins and a controlled cost base.

Recurring Revenues

Total ARR at 30 June 2026 was £53.2m (H1 2025: £50.9m on a constant currency basis), representing constant currency growth of 5%. Constant currency ARR growth of 5% is driven by strong new business wins in EMEA and the Americas.

Net revenue retention for the Group for the year to 30 June 2026 was 98% (H1 2025: 102%). The reduction in net revenue retention in the period related to the ending of one immigration related contract in Australia. The government programme in Australia received a legal challenge which resulted in the scheme being withdrawn. Excluding this contract, the net revenue retention for the period would have been 100%.

The Group's ARR of £53.2m provides strong visibility of future revenues, derived from long term contracts.

Revenue

Total revenue for the six months ended 30 June 2026 grew to £26.9m (H1 2025: £24.8m). Adjusting H1 2025 revenues for constant currency using average exchange rates for the first half of 2026, would have resulted in revenues being £25.4m as opposed to £24.8m. On a constant currency basis, revenues in the first half of 2026 were 6% higher than revenues in the first half of 2025. All regions experienced growth in the period.

Gross Profit

Gross profit for the six months to 30 June 2026 was £18.0m (H1 2025: £16.7m), an increase of £1.3m. Gross margin for the six months to 30 June 2026 was 66.7% (H1 2025: 67.5%), a reduction of 80 bps.

The reduction in gross margin was anticipated and was principally driven by the commencement of the full-service Northern Ireland contract in the period which has a lower margin profile.

Administrative Expenses

Underlying administrative expenses, which adjust for exceptional items and share-based payment expense/credit, fell from £7.2m to £6.6m, demonstrating the effect of efficiencies generated in H2 2025 and the continuing disciplined approach to the cost base of the Group.

Total administrative expenses for the six months to 30 June 2026 were £8.9m (H1 2025: £43.9m), with H1 2025 impacted by the provision made in relation to the Buddi Litigation.

Included within administrative expenses for the six months to 30 June 2026 are research and development costs of £1.7m (H1 2025: £1.9m). Development costs of £0.5m have been capitalised in the six months to 30 June 2026 (H1 2025: £0.6m).

Non-Underlying Items

The Group also incurred additional legal and other litigation related costs of £1.8m (H1 2025: £42.6m, of which the majority related to increased provisions of £35.8m). At the start of H1 2026, a settlement was agreed in relation to the Buddi Litigation. The Group continues to pursue the SM Proceedings, to which the majority of the non-underlying fees in the period relate. No amounts potentially recoverable from Sara Murray or others have been recognised in these results.

In the six months to 30 June 2026, a share-based payment charge of £0.2m (H1 2025: credit of £11.2m) was recognised, relating to the LTIP scheme and final tranche of growth shares. The prior period share-based payment credit related to the unwinding of the growth share charges in relation to bad leavers from the scheme.

Taxation

The total tax charge for the six months ended 30 June 2026 was £1.8m (H1 2025: £3.2m). On an adjusted basis, the total tax charge for the Group was £1.7m (H1 2025: £1.7m), representing an effective tax rate of 15% (H1 2025: 15%).

The Group continues to review potential tax implications arising from ongoing litigation processes.

Statutory Results

The Group reported a profit for the six months ended 30 June 2026 of £7.7m (H1 2025: loss of £28.9m). The improvement year on year was a result of prior year provisioning for ongoing litigation, now settled, and a prior year exceptional foreign exchange loss in relation to the repatriation of funds held in anticipation of an acquisition.

Earnings per Share

Adjusted Basic Earnings per Share increased to 3.5 pence (H1 2025: 2.8 pence). Basic earnings per share increased from a 10.0 pence loss per share - as a result of the provisioning in relation to ongoing litigation put in place during the six months to 30 June 2025 - to 2.6p earnings per share.

Statement of Financial Position

The Group retains a strong balance sheet with net assets at 30 June 2026 of £99.0m (30 June 2025: £85.4m). The net asset position has strengthened as a result of the return to profitable trading.

The Group's balance sheet is underpinned by a strong cash position at 30 June 2026 of £67.1m (30 June 2025: £96.7m). The reduction in the Group's cash from 2025 relates to payments made in relation to the Buddi Litigation.

Trade debtors at 30 June 2026 were £5.5m (30 June 2025: £6.4m). Of total trade debtors of £5.5m, £0.1m were overdue as at 30 June 2026 (30 June 2025: £0.7m). Trade debtors have benefited from the implementation of weekly debt reporting within the business.

Provisions were £1.1m at 30 June 2026 (30 June 2025: £42.7m) and related principally to fees expected to be incurred to settlement. No legal fees have been provided in relation to ongoing litigation beyond 30 June 2026, which will be expensed as incurred.

Cash flow

Adjusted free cash flow for the six months ended 30 June 2026 was £9.6m (H1 2025: £6.7m) demonstrating strong cash conversion in the period.

Statutory net cash outflow from operating activities for the six months to 30 June 2026 was £24.2m (H1 2025: inflow of £5.4m). Of the cash outflow in the period, £33.4m related to payments in relation to the settlement of the Buddi Litigation. Exceptional cash outflows in relation to legal fees reduced to £2.6m in H1 2026 (H1 2025: £5.3m).

Statement on Principal Risks and Uncertainties

Pursuant to the requirements of the Disclosure and Transparency Rules the Group provides the following information on its principal risks and uncertainties. The Group considers strategic, operational and financial risks and identifies actions to mitigate those risks. These risk profiles are updated at least annually. The principal risks and uncertainties detailed within the Group's 2025 Annual Report remain applicable for the first six months of the financial year. The Group's 2025 Annual Report is available from the Big Technologies website: https://www.buddi.com/investors/

Related party transactions during the period are disclosed in Note 13.

Unaudited condensed consolidated statement of comprehensive income
for the six months ended 30 June 2026

		Unaudited six months ended 30 June 2026 £'000		Unaudited six months ended 30 June 2025 Restated £'000		Audited Year ended 31 December 2025 £'000
	Note
Revenue	2	26,922		24,796		49,727
Cost of sales		(8,962)		(8,059)		(16,874)
Gross profit		17,960		16,737		32,853
Administrative expenses		(8,878)		(43,879)		(55,890)
Other operating income		14		6		22
Operating (loss)/profit		9,096		(27,136)		(23,015)
Analysed as:
Adjusted EBITDA		14,182		12,508		24,600
Amortisation of acquired intangibles		(234)		(233)		(443)
Amortisation of development costs		(445)		(666)		(1,340)
Depreciation		(2,295)		(2,323)		(4,730)
Share-based payment (expense)/credit		(216)		11,162		10,774
Legal and associated costs		(1,781)		(7,559)		(8,142)
Other exceptional costs		(115)		(671)		(880)
Foreign exchange loss on repatriation		-		(3,996)		(3,996)
Acquisition-related costs		-		(358)		(358)
Provision for settlement		-		(35,000)		(38,500)
Operating profit/(loss)		9,096		(27,136)		(23,015)
Finance income		481		1,488		2,661
Finance expenses		(70)		(63)		(131)
Profit/(loss) before taxation		9,507		(25,711)		(20,485)
Taxation	4	(1,812)		(3,166)		(2,700)
Profit/(loss) for the period		7,695		(28,877)		(23,185)
Other comprehensive (expense) /income:
Exchange differences on translation of foreign operations		(340)		(4)		(253)
Cash flow hedges reclassified to income statement		7		-		-
Gain on effective cash flow hedges		112		-		-
Deferred tax on cash flow hedges		(30)		-		-
Total comprehensive income/(loss) for the period		7,444		(28,881)		(23,438)
Basic earnings per share (pence)	5	2.6p		(10.0)p		(8.0)p
Diluted earnings per share (pence)	5	2.6p		(10.0)p		(8.0)p

Unaudited condensed consolidated statement of financial position

as at 30 June 2026

			Unaudited 30 June 2026 £'000		Unaudited 30 June 2025 Restated £'000		Audited 31 December 2025 £'000
Assets		Note
Goodwill			13,359		13,359		13,359
Acquired and other intangible assets			4,310		4,675		4,465
Property, plant and equipment			4,638		4,968		4,657
Right-of-use assets			1,758		1,625		1,932
Deferred tax assets			1,358		906		1,142
Other receivables		6	591		512		807
Long-term financial assets			396		396		396
Non-current assets			26,410		26,441		26,758
Inventories			6,575		7,272		7,136
Trade and other receivables		6	15,802		8,716		16,932
Financial assets			170		-		-
Cash and cash equivalents		7	67,083		96,699		93,367
Current assets			89,630		112,687		117,435
Total assets			116,040		139,128		144,193
Liabilities
Lease liabilities			322		303		321
Financial liabilities			51		-		-
Trade and other payables		8	12,857		7,678		9,876
Corporation tax liability			-		510		-
Provisions		9	1,130		42,650		39,695
Current liabilities			14,360		51,141		49,892
Net current assets			75,270		61,546		67,543
Lease liabilities			1,627		1,474		1,784
Deferred tax liabilities			178		251		199
Trade and other payables		8	921		822		1,026
Non-current liabilities			2,726		2,547		3,009
Total liabilities			17,086		53,688		52,901
Net assets			98,954		85,440		91,292
Equity
Share capital		10	3,009		2,986		3,009
Share premium			39,095		39,095		39,095
Own Shares			(13,085)		(13,085)		(13,085)
Other reserves			(648)		(97)		(346)
Retained earnings			70,583		56,541		62,619
Total equity			98,954		85,440		91,292

Unaudited condensed consolidated statement of changes in equity

for the six months ended 30 June 2026

	Share capital £'000	Share premium £'000	Own Shares £'000	Other reserves £'000	Retained earnings £'000	Total equity £'000
Balance at 1 January 2025 (as previously reported)	2,986	39,095	(10,101)	(93)	96,234	128,121
Prior period restatement*	-	-	-	-	592	592
Balance at 1 January 2025 (restated)	2,986	39,095	(10,101)	(93)	96,826	128,713
Loss for the year	-	-	-	-	(23,185)	(23,185)
Other comprehensive expense for the year	-	-	-	(253)	-	(253)
Total comprehensive loss for the year	-	-	-	(253)	(23,185)	(23,438)
Share-based payments	-	-	-	-	(10,774)	(10,774)
Deferred tax on share-based payments	-	-	-	-	(238)	(238)
Issue of shares, net of share issue costs	23	-	-	-	-	23
Stamp duty on purchase of shares	-	-	-	-	(10)	(10)
Share buyback programme	-	-	(2,984)	-	-	(2,984)
Balance at 31 December 2025	3,009	39,095	(13,085)	(346)	62,619	91,292
*The prior period restatement is detailed further in note 15.
	Share capital £'000	Share premium £'000	Own Shares £'000	Other reserves £'000	Retained earnings £'000	Total equity £'000
Balance at 1 January 2025 (as previously reported)	2,986	39,095	(10,101)	(93)	96,234	128,121
Prior period restatement*	-	-	-	-	592	592
Balance at 1 January 2025 (restated)	2,986	39,095	(10,101)	(93)	96,826	128,713
Loss for the period (restated)	-	-	-	-	(28,877)	(28,877)
Other comprehensive expense for the period	-	-	-	(4)	-	(4)
Total comprehensive loss for the period (restated)	-	-	-	(4)	(28,877)	(28,881)
Share-based payments	-	-	-	-	(11,170)	(11,170)
Deferred tax on share-based payments	-	-	-	-	(238)	(238)
Share buyback programme	-	-	(2,984)	-	-	(2,984)
Balance at 30 June 2025 (restated)	2,986	39,095	(13,085)	(97)	56,541	85,440

*The prior period restatement is detailed further in note 15.

	Share capital £'000	Share premium £'000	Own Shares £'000	Other reserves £'000	Retained earnings £'000	Total equity £'000
Balance at 1 January 2026	3,009	39,095	(13,085)	(346)	62,619	91,292
Profit for the period	-	-	-	-	7,695	7,695
Exchange differences on translation of foreign operations	-	-	-	(340)	-	(340)
Cash flow hedges reclassified to income statement	-	-	-	7	-	7
Gain on effective cash flow hedges	-	-	-	112	-	112
Deferred tax on cash flow hedges	-	-	-	(30)	-	(30)
Total comprehensive (expense)/ income for the period	-	-	-	(251)	7,695	7,444
Share-based payments	-	-	-	-	210	210
Deferred tax on share-based payments	-	-	-	-	8	8
Recycled from cumulative translation reserve	-	-	-	(51)	51	-
Balance at 30 June 2026	3,009	39,095	(13,085)	(648)	70,583	98,954

Unaudited condensed consolidated statement of cash flows

for the six months ended 30 June 2026

	Note	Unaudited six months ended 30 June 2026 £'000		Unaudited six months ended 30 June 2025 £'000		Audited Year ended 31 December 2025 £'000
Cash flows from operating activities
Profit/(loss) before tax		9,507		(25,711)		(20,485)
Adjustments for:
Depreciation of property, plant and equipment		2,161		2,192		4,424
Depreciation of right-of-use assets		134		131		306
Amortisation of intangible assets		679		899		1,783
Share-based payments expense/(credit)	11	210		(11,170)		(10,774)
Finance income		(481)		(1,488)		(2,661)
Finance expenses		70		63		131
Changes in:
Inventories		560		(67)		69
Trade and other receivables		1,419		5,256		(270)
Trade and other payables		2,683		1,431		4,782
Provisions		(38,565)		35,832		32,877
Cash (used in)/generated from operating activities		(21,623)		7,368		10,182
Taxes paid		(2,555)		(1,985)		(6,426)
Net cash flows (used in)/generated from operating activities		(24,178)		5,383		3,756
Cash flows from investing activities
Purchase of property, plant and equipment		(48)		(33)		(123)
Purchase of intangible assets		-		(159)		(180)
Own work capitalised		(1,969)		(1,946)		(3,804)
Capitalised development costs		(525)		(566)		(1,218)
Interest received		481		1,488		2,626
Net cash used in investing activities		(2,061)		(1,216)		(2,699)
Cash flows from financing activities
Repayment of lease liabilities		(222)		(167)		(389)
Interest paid		(6)		(4)		(7)
Treasury shares purchased via share buyback scheme		-		(2,984)		(2,994)
Cash flows used in financing activities		(228)		(3,155)		(3,390)
Net (decrease)/increase in cash and cash equivalents		(26,467)		1,012		(2,333)
Cash and cash equivalents at the beginning of the period		93,367		95,730		95,730
Effect of exchange rate changes on cash and cash equivalents		183		(43)		(30)
Cash and cash equivalents at the end of the period	7	67,083		96,699		93,367

Notes to the unaudited condensed interim consolidated financial statements

For the six months ended 30 June 2026

1.   General information and basis of preparation

Big Technologies PLC is a public limited company incorporated in the United Kingdom, listed on the Alternative Investment Market ('AIM') of the London Stock Exchange. The Company is domiciled in the United Kingdom and its registered office is Talbot House, 17 Church Street, Rickmansworth, WD3 1DE. The unaudited interim consolidated financial statements comprise the Company and its subsidiaries (together referred to as the 'Group').

The principal activity of the Group is the development and delivery of remote monitoring technologies and services to a range of domestic and international customers.

The Directors confirm that, to the best of their knowledge, the interim financial statements have been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the United Kingdom and the AIM Rules for Companies, and that the interim report includes a fair review of the information required.

The condensed interim financial statements should be read in conjunction with the Group's latest annual consolidated financial statements, for the year ended 31 December 2025.

These interim financial statements do not include all of the information required for a complete set of financial statements prepared in accordance with IFRS Standards. However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Group's financial position and performance since the last annual consolidated financial statements.

The financial information provided for the six-month period ended 30 June 2026 is unaudited, however, the same accounting policies, presentation and methods of computation have been followed in these interim financial statements as those which were applied in the preparation of the Group's annual consolidated financial statements for the year ended 31 December 2025.

These condensed consolidated interim financial statements for the six months ended 30 June 2026 do not constitute statutory accounts as defined in section 434 of the Companies Act 2006.  A copy of the most recent statutory accounts for the year ended 31 December 2025 has been delivered to the Registrar of Companies.  The auditor's report on these accounts was unqualified and did not contain a statement under section 498 of the Companies Act 2006.

These interim financial statements were authorised for issue by the Company's board of directors on 12 September 2026.

1.1 Going concern

The Directors have, at the time of approving these interim financial statements, a reasonable expectation that the Company and the Group have adequate resources to continue in operation for the period to 30 September 2027. The Group's forecasts and projections, taking into account reasonable possible changes in trading performance, show that the Group has sufficient financial resources, together with assets that are expected to generate cash flow in the normal course of business. Accordingly, the Directors have adopted the going concern basis in preparing these interim financial statements.

2.   Segment reporting

The Group derives revenue from the delivery of remote monitoring technologies and services to a range of domestic and international customers. The income streams are all derived from the utilisation of these products which, in all aspects except details of revenue, are reviewed and managed together within the Group and as such there is only considered to be one segment. The Group operates across three regions: Europe, Asia-Pacific and the Americas, and the Board of Directors monitors revenue on this basis.

Revenue for each of the geographical areas is as follows:

	Unaudited H1 2026 £'000		Unaudited H1 2025 £'000		Audited FY 2025 £'000
Europe	3,989		4,063		6,369
Asia-Pacific	17,948		16,557		33,657
Americas	4,985		4,176		9,701
	26,922		24,796		49,727

Assets and liabilities by segment are not regularly reviewed by the Board of Directors on a monthly basis, nor are they used as key decision-making tools, and therefore are not disclosed here.

Revenues are disaggregated as follows:

	Unaudited H1 2026 £'000		Unaudited H1 2025 £'000		Audited FY 2025 £'000
Sales of goods	22		41		61
Delivery of services	26,900		24,755		49,666
	26,922		24,796		49,727

The nature of the Group's operations mean that recorded financial performance is not seasonal or cyclical in nature. The majority of revenues are derived from delivery of services to customers over time under long-term contracts.

3.   Alternative performance measures

These items are included in normal operating costs of the business, but are significant cash and non-cash expenses that are separately disclosed because of their size, nature or incidence. It is the Group's view that excluding them from operating profit gives a better representation of the underlying performance of the business in the period.

	Unaudited H1 2026 £'000		Unaudited H1 2025 Restated £'000		Audited FY 2025 £'000
Amortisation of acquired intangibles	234		233		443
Provision for settlement	-		35,000		38,500
Legal and other litigation-related costs	1,781		7,559		8,142
Foreign exchange loss on repatriation	-		3,996		3,996
Other exceptional costs	115		671		880
Acquisition related costs	-		358		358
Total adjusting operating items	2,130		47,817		52,319
Share-based payments expense/(credit)	216		(11,162)		(10,774)
Total adjusting items and share-based payments before tax	2,346		36,655		41,545
Tax effect of adjusting items and share-based payments	93		415		(256)
Total adjusting items and share-based payments after tax	2,439		37,070		41,289

Share-based payments expense

These costs are excluded from the adjusted results of the Group on the basis the costs are non-cash charges arising from recognition of the fair value of share options and other share-based incentives granted to employees of the Group. As such, they are not considered reflective of the core trading performance of the Group.

Amortisation of acquired intangibles

These costs are excluded from the adjusted results of the Group since they are non-cash charges arising from investment activities. As such, they are not considered reflective of the core trading performance of the Group.

Legal and other litigation-related costs

These costs are excluded from the adjusted results of the Group as they are not considered reflective of the core trading performance of the Group. Further details in relation to the ongoing litigation can be found in Note 9.

Foreign exchange on repatriation

The Group held a significant cash balance in US Dollars at 31 December 2024 in anticipation of a potential US acquisition in early 2025. With the acquisition not proceeding, the cash was repatriated. As such, the amount is not considered to be a component of the core trading performance of the Group.

Other exceptional costs

These costs, which relate to one-off overseas tax remediation costs incurred in the period, and the substantial changes in Board composition in the prior year, are excluded since they do not relate to the core trading performance of the Group.

Acquisition-related costs

These costs relate to the due diligence exploring possible value-enhancing opportunities and are excluded from the adjusted results of the Group since the costs are not considered reflective of the core trading performance of the Group.

4.   Taxation

Current tax is charged at 25% for the period, representing the best estimate of the average annual effective current tax rate expected to apply for the full year, applied to the pre-tax income for the current period.

Deferred tax recognised in the period relates to share-based payments, acquired intangible assets and fixed asset timing differences.

The Group continues to assess the tax impact, if any, in relation to ongoing litigation proceedings referred to in Note 9.

	Unaudited H1 2026 £'000		Unaudited H1 2025 Restated £'000		Audited FY 2025 £'000
Current tax
For the financial period	1,593		3,292		2,964
Adjustments in respect of prior periods	-		-		(141)
Overseas tax payable	494		-		287
	2,087		3,292		3,110
Deferred tax
Origination and reversal of temporary timing differences	(256)		(146)		(426)
Related to share-based payments	(19)		20		16
	(275)		(126)		(410)
Total taxation	1,812		3,166		2,700

In addition to taxation recognised in the consolidated income statement, the following amounts relating to tax have been recognised directly in equity:

	Unaudited H1 2026 £'000		Unaudited H1 2025 £'000		Audited FY 2025 £'000
Deferred tax
Related to share-based payments	8		(238)		(238)
Related to cashflow hedges	30		-		-
Total taxation recognised directly in equity	38		(238)		(238)

5.   Earnings/(loss) per share

The calculation of the basic and diluted earnings per share is based on the following data:

	Unaudited H1 2026 £'000		Unaudited H1 2025 Restated £'000		Audited FY 2025 £'000
Profit/(loss) for the purpose of basic and diluted earnings per share being net profit attributable to equity holders of the parent	7,695		(28,877)		(23,185)
Adjustments for:
Adjusting items	2,130		47,817		52,319
Share-based payments expense/(credit)	216		(11,162)		(10,774)
Tax effect of adjusting items and share-based payments	93		415		(256)
Adjusted earnings	10,134		8,193		18,104

	Unaudited H1 2026 No. shares		Unaudited H1 2025 No. shares		Audited FY 2025 No. shares
Weighted average number of ordinary shares	300,944,313		298,568,721		299,525,466
Less own shares held (weighted average)	(10,384,944)		(9,201,223)		(9,797,948)
Weighted average number of Ordinary shares for the purpose of basic earnings per share	290,559,369		289,367,498		289,727,518
Effect of dilutive potential Ordinary shares/share options	1,146,416		-		-
Weighted average number of Ordinary shares for the purpose of diluted earnings per share	291,705,785		289,367,498		289,727,518
Effect of dilutive potential Ordinary shares/share options for the purpose of calculating adjusted diluted earnings per share	-		3,528,264		2,752,684
Weighted average number of Ordinary shares for the purpose of adjusted diluted earnings per share	291,705,785		292,895,762		292,480,202

The calculation of the basic and diluted earnings per share is based on the following data:

Basic earnings per share	Unaudited H1 2026 Pence		Unaudited H1 2025 Restated Pence		Audited FY 2025 Pence
Basic earnings per share	2.6		(10.0)		(8.0)
Adjustments for:
Adjusting items	0.7		16.5		18.0
Share-based payments expense	0.1		(3.8)		(3.7)
Tax effect of adjusting items and share-based payments	0.1		0.1		(0.1)
Adjusted basic earnings per share	3.5		2.8		6.2
Diluted earnings per share	Unaudited H1 2026 Pence		Unaudited H1 2025 Restated Pence		Audited FY 2025 Pence
Diluted earnings per share	2.6		(10.0)		(8.0)
Adjustments for:
Adjusting items	0.7		16.5		18.0
Share-based payments expense	0.1		(3.8)		(3.7)
Tax effect of adjusting items and share-based payments	0.1		0.1		(0.1)
Adjusted diluted earnings per share	3.5		2.8		6.2

The adjusted earnings per share has been calculated on the basis of profit before adjusting items and share-based payments, net of tax. The Directors consider that this calculation gives a better understanding of the Group's earnings per share in the current and prior periods.

6.   Trade and other receivables

	Unaudited H1 2026 £'000		Unaudited H1 2025 Restated £'000		Audited FY 2025 £'000
Trade receivables - net	5,478		6,395		6,843
Corporation tax receivable	4,619		-		4,116
Other taxation and social security	3,980		1,470		3,713
Prepayments	1,107		435		1,591
Other receivables	827		928		926
Contract assets	382		-		550
	16,393		9,228		17,739
Due for settlement within 12 months	15,802		8,716		16,932
Due for settlement after 12 months	591		512		807
	16,393		9,228		17,739

7.   Cash and cash equivalents

The carrying amounts of the cash and cash equivalents are denominated in the following currencies:

	Unaudited H1 2026 £'000		Unaudited H1 2025 £'000		Audited FY 2025 £'000
Pounds Sterling	57,375		73,068		82,620
US Dollar	2,498		2,147		3,915
Australian Dollar	3,605		10,582		2,886
New Zealand Dollar	1,082		8,918		2,131
Euro	898		1,421		717
Swiss Francs	931		207		560
Canadian Dollar	329		175		346
Other	365		181		192
	67,083		96,699		93,367

Net cash

Net cash comprises cash and cash equivalents and lease liabilities.

	Unaudited H1 2026 £'000		Unaudited H1 2025 £'000		Audited FY 2025 £'000
Cash and cash equivalents	67,083		96,699		93,367
Lease liabilities	(1,949)		(1,777)		(2,105)
	65,134		94,922		91,262

8.   Trade and other payables

	Unaudited H1 2026 £'000		Unaudited H1 2025 £'000		Audited FY 2025 £'000
Trade payables	1,923		1,728		2,835
Accruals	3,004		3,302		3,125
Other payables	6,491		964		1,349
Other taxation and social security	294		506		623
Contract liabilities	2,066		2,000		2,970
	13,778		8,500		10,902
Due for settlement within 12 months	12,857		7,678		9,876
Due for settlement after 12 months	921		822		1,026
	13,778		8,500		10,902

Included within other creditors is £5.1m relating to the settlement of the Buddi Litigation. The remaining payment will be made in equal instalments over the next 13 months.

9.   Provisions

The movements were as follows:

	Unaudited H1 2026 £'000		Unaudited H1 2025 £'000		Audited FY 2025 £'000
At the start of the period	39,695		6,818		6,818
Charged to profit or loss	380		42,559		46,216
Utilised	(38,945)		(6,727)		(13,339)
At the end of the period	1,130		42,650		39,695

Litigation outside the ordinary course of business

The Buddi Litigation

On 16 January 2026, the Group entered into a settlement agreement in respect of a claim filed with the High Court in 2023 by shareholders who represented an interest of approximately 7.9% of the share capital of Buddi Limited as at May 2018. The Group agreed to pay £31.5m immediately, and the remaining £7.0m in equal instalments over 18 months. Following the agreement in the period, the remaining provision has been utilised and a creditor recognised in respect of the remaining outstanding payments.

The SM Proceedings

The Group continues to incur legal fees in relation to the pursuit of the SM Proceedings. The Group has made a provision for estimated legal fees to be incurred to settle the SM Proceedings, based on the assumption that settlement will occur in H2 2026. No amounts have been provided in relation to ongoing litigation costs, which will be expensed in future periods as they are incurred. Total legal fees provided at 30 June 2026 in relation to the SM proceedings were £0.6m (H1 2025: £4.3m).

No amounts potentially recoverable from Sara Murray or others as a result of these proceedings have been recognised.

Other ongoing litigation in the ordinary course of business

The Company and its subsidiaries are, from time to time, parties to legal proceedings and claims which arise in the ordinary course of business. The Directors do not anticipate that the outcome of these proceedings and claims will have a material adverse effect on the Group's financial position or on the results of its operations. As at 30 June 2026 the Group has provided £0.5m (H1 2025: £nil) in relation to employment claims raised against the Group.

10.  Share capital

The allotted, called up and fully paid share capital is made up of 300,944,313 ordinary shares of £0.01 each.

Investment in own shares

At 30 June 2026, the Company held 5,384,944 (H1 2025: 5,384,944) of its own shares in the Employee Benefit Trust, with a nominal value of £53,849 (H1 2025: £53,849). The Employee Benefit Trust has waived any entitlement to the receipt of dividends in respect of its holding of the Company's ordinary shares. The market value of these shares at 30 June 2026 was £5,169,546 (H1 2025: £5,051,077). In the current period, nil (H1 2025: nil) were repurchased and transferred into the Employee Benefit Trust, with nil (H1 2025: 15,000) reissued on exercise of share options.

11.  Share-based payments

The Group has a number of equity-settled share-based payment arrangements in operation, the details of which are disclosed in note 23, on pages 77-79 of the 2025 Annual Report and Accounts. The schemes were established to reward and incentivise the senior management team and employees to deliver share price growth. The charge made in respect of share-based payments is as follows:

	Unaudited H1 2026 £'000		Unaudited H1 2025 £'000		Audited FY 2025 £'000
LTIP	42		61		103
Growth Share Plan	168		(11,231)		(10,877)
Share-based payments charge (IFRS 2)	210		(11,170)		(10,774)
Employers' tax charge in relation to share awards	6		8		-
Total (credit)/charge in respect of share-based payments	216		(11,162)		(10,774)

12.  Principal risks and uncertainties

The principal risks and uncertainties impacting the Group are described on pages 15-18 of the 2025 Annual Report and Accounts and remain applicable at 30 June 2026.

They include: reliance on key customers, failure to manage growth, change in government policy, challenges in expanding the product portfolio, competitor actions, reliance on third-party technology and communication systems, reputational risk, dependence on partners, loss of key personnel, supply chain, product liability, foreign exchange risk, credit risk, business taxation, bid pricing/key financial terms, litigation, cyber security and business interruption, intellectual property/patents and operating in global markets.

13.  Related party transactions

Transactions between the Company and its subsidiaries have been eliminated on consolidation and therefore not disclosed separately.

Other than the remuneration of key management personnel, which comprised the Directors, the Group's other related party transactions were as follows:

£nil (H1 2025: £50,000) was paid to TFM Developments Ltd, a company of which Sara Murray is a director. The transaction related to a license fee paid in respect of a patent owned by the company. The facts and circumstances surrounding the intellectual property in relation to the license fee charged by TFM Developments Ltd is subject to ongoing litigation.

£nil (H1 2025: £116,000) was paid to Brennan and Partners Limited, a company controlled by Alexander Brennan, for additional fees payable to Mr Brennan over and above his normal contracted days for his role as Non-Executive Chair of the Company. The arrangement ceased on 31 May 2025.

The related party transactions for the year ended 31 December 2025 as defined by International Accounting Standard No.24 'Related Party Disclosures' are disclosed in note 25 of the Big Technologies plc Annual Report for the year ended 31 December 2025.

14.  Reconciliation of alternative performance measures

	Unaudited H1 2026 £'000		Unaudited H1 2025 £'000		Audited FY 2025 £'000
Statutory operating profit / (loss)	9,096		(27,136)		(23,015)
Amortisation of acquired intangibles	234		233		443
Litigation and associated costs	1,781		7,559		8,142
Provision for settlement	-		35,000		38,500
Foreign exchange loss	-		3,996		3,996
Other exceptional costs	115		671		880
Acquisition related costs	-		358		358
Share-based payments expense/(credit)	216		(11,162)		(10,774)
Total adjusting items and share-based payments before tax	2,346		36,655		41,545
Adjusted operating profit	11,442		9,519		18,530

15.  Prior period adjustment

The Group manufactures devices, which it then leases out to customers. Historically, it was elected to take super deductions of the Annual Investment Allowance, and fully expense these.

In the preparation of the 2025 Annual Report, following the receipt of new tax advice and considering the impact of relevant tax case law, the Group concluded that the appropriate treatment would have been to cap this at the amount of the Annual Investment Allowance. Accordingly, the Group restated its financial statements in accordance with IAS 8 'Accounting Policies, Changes in Accounting Estimates and Errors'.

As a result of this change, an insufficient deferred tax asset was recognised in the H1 2025 results.

The impact of the restatements on the consolidated statement of financial position is presented below:

	As previously reported 30 June 2025	Restatement as at 1 January 2025	Restatement half year-ended 30 June 2025	Restatement cumulative to 30 June 2025	Restated 30 June 2025
	£'000	£'000	£'000	£'000	£'000
Non-current assets/liabilities
Deferred tax asset	172	670	64	734	906
Deferred tax liabilities	(1,247)	972	24	996	(251)
Current assets/liabilities
Trade and other receivables	9,385	(669)	-	(669)	8,716
Corporation tax liability	-	(381)	(129)	(510)	(510)
Equity
Retained earnings	55,990	592	(41)	551	56,541

The impact of the restatements on the consolidated statement of comprehensive income is presented below:

	As previously reported H1 2025 £'000	Impact of restatement - deferred tax £'000	Impact of restatement - current tax £'000	Restated H1 2025 £'000
Taxation	3,125	129	(88)	3,166

16.  Statement of directors' responsibilities

The Directors confirm that these condensed interim financial statements have been prepared in accordance with UK-adopted International Accounting Standard 34, 'Interim Financial Reporting'.

A list of current directors is maintained on the Big Technologies plc website: https://www.buddi.com/investors/

Copies of this statement are available on the investor relations page of our website (https://www.buddi.com/investors/)

By order of the Board

Mike Johns                                          

Chief Financial Officer                          

12 September 2026

 

END